trial

Electroconvulsive Therapy in Clozapine-resistant Schizophrenia

NCTId NCT02159001
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Unknown
Enrollment 20 (estimated)
Sponsored by Niuvanniemi Hospital
Primary completion 2017-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Unknown
Enrollment
20 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Single
Start
2014-06
Primary completion
2017-12
Eligibility
ALL · 18 Years · 64 Years

Interventions & indications

Drugs
electroconvulsive therapy

Sponsors

Niuvanniemi HospitalLead Sponsor

Sites

1 total
Kuopio, Finland

Facts & assertions

4 sourced
Enrollment
20
Phase
NA
Primary Completion Date
2017-12
Status
UNKNOWN
relationships
The graph out of here
drug
electroconvulsive therapy
drug
lead_sponsor
Niuvanniemi Hospital
company
indication
Schizophrenia
indication
Schizoaffective Disorder
indication
Schizophrenia
indication